Nationwide Financial institution of Canada FI raised its place in stocks of Quest Diagnostics Integrated (NYSE:DGX – Unfastened Record) through 24.2% within the third quarter, Holdings Channel stories. The company owned 31,336 stocks of the scientific analysis corporate’s inventory after obtaining an extra 6,114 stocks all through the length. Nationwide Financial institution of Canada FI’s holdings in Quest Diagnostics have been value $3,789,000 on the finish of the latest reporting length.

A number of different institutional buyers have additionally added to or decreased their stakes within the corporate. Forefront Crew Inc. raised its place in Quest Diagnostics through 4.8% all through the primary quarter. Forefront Crew Inc. now owns 14,014,030 stocks of the scientific analysis corporate’s inventory valued at $1,917,961,000 after buying an extra 636,301 stocks within the final quarter. Windfall Capital Advisors LLC raised its place in Quest Diagnostics through 14,887.6% all through the primary quarter. Windfall Capital Advisors LLC now owns 4,331,410 stocks of the scientific analysis corporate’s inventory valued at $30,615,000 after buying an extra 4,302,510 stocks within the final quarter. Victory Capital Control Inc. raised its place in Quest Diagnostics through 3.1% all through the second one quarter. Victory Capital Control Inc. now owns 3,233,625 stocks of the scientific analysis corporate’s inventory valued at $454,518,000 after buying an extra 97,425 stocks within the final quarter. Geode Capital Control LLC raised its place in Quest Diagnostics through 3.1% all through the second one quarter. Geode Capital Control LLC now owns 2,422,912 stocks of the scientific analysis corporate’s inventory valued at $339,688,000 after buying an extra 72,447 stocks within the final quarter. In spite of everything, Wellington Control Crew LLP raised its place in Quest Diagnostics through 46,022.7% all through the primary quarter. Wellington Control Crew LLP now owns 1,914,554 stocks of the scientific analysis corporate’s inventory valued at $270,871,000 after buying an extra 1,910,403 stocks within the final quarter. 87.76% of the inventory is lately owned through institutional buyers and hedge price range.

Quest Diagnostics Inventory Efficiency

Stocks of Quest Diagnostics inventory opened at $136.74 on Friday. The corporate has a handy guide a rough ratio of one.01, a present ratio of one.12 and a debt-to-equity ratio of 0.61. Quest Diagnostics Integrated has a twelve month low of $119.59 and a twelve month top of $158.34. The inventory has a marketplace cap of $15.37 billion, a price-to-earnings ratio of 20.53 and a beta of 0.91. The corporate’s fifty day transferring reasonable is $132.85 and its 200 day transferring reasonable is $133.04.

Quest Diagnostics (NYSE:DGX – Get Unfastened Record) final issued its quarterly revenue knowledge on Tuesday, October twenty fourth. The scientific analysis corporate reported $2.22 revenue according to proportion for the quarter, topping the consensus estimate of $2.19 through $0.03. The corporate had earnings of $2.30 billion for the quarter, in comparison to analysts’ expectancies of $2.27 billion. Quest Diagnostics had a web margin of 8.21% and a go back on fairness of 15.80%. Quest Diagnostics’s earnings for the quarter used to be down 7.7% on a year-over-year foundation. All the way through the similar quarter within the earlier yr, the company posted $2.36 revenue according to proportion. Promote-side analysts forecast that Quest Diagnostics Integrated will publish 8.71 EPS for the present yr.

Quest Diagnostics Dividend Announcement

The corporate additionally just lately declared a quarterly dividend, which will probably be paid on Wednesday, January thirty first. Shareholders of report on Wednesday, January seventeenth will probably be given a dividend of $0.71 according to proportion. The ex-dividend date is Tuesday, January sixteenth. This represents a $2.84 dividend on an annualized foundation and a yield of two.08%. Quest Diagnostics’s dividend payout ratio (DPR) is lately 42.64%.

Analyst Scores Adjustments

A number of brokerages have commented on DGX. Piper Sandler boosted their payment function on stocks of Quest Diagnostics from $130.00 to $140.00 and gave the corporate a “impartial” score in a analysis document on Monday, November sixth. JPMorgan Chase & Co. boosted their goal payment on stocks of Quest Diagnostics from $148.00 to $149.00 and gave the inventory a “impartial” score in a analysis word on Friday, November seventeenth. Financial institution of The united states raised stocks of Quest Diagnostics from a “impartial” score to a “purchase” score and boosted their goal payment for the inventory from $140.00 to $160.00 in a analysis word on Tuesday, December twelfth. Evercore ISI reduced their goal payment on stocks of Quest Diagnostics from $136.00 to $130.00 in a analysis word on Wednesday, October eleventh. In spite of everything, UBS Crew boosted their goal payment on stocks of Quest Diagnostics from $135.00 to $137.00 and gave the inventory a “impartial” score in a analysis word on Thursday, December seventh. 9 analysts have rated the inventory with a grasp score and 3 have assigned a purchase score to the corporate’s inventory. Consistent with MarketBeat.com, the inventory at this time has a mean score of “Hang” and a mean payment goal of $146.75.

Learn Our Newest Inventory Record on DGX

Quest Diagnostics Corporate Profile

(Unfastened Record)

Quest Diagnostics Integrated supplies diagnostic checking out, knowledge, and services and products in america and across the world. The corporate develops and delivers diagnostic knowledge services and products, similar to ordinary checking out, non-routine and complicated medical checking out, anatomic pathology checking out, and different diagnostic knowledge services and products.

Featured Articles

Need to see what different hedge price range are preserving DGX? Consult with HoldingsChannel.com to get the most recent 13F filings and insider trades for Quest Diagnostics Integrated (NYSE:DGX – Unfastened Record).

Obtain Information & Scores for Quest Diagnostics Day-to-day – Input your e mail cope with under to obtain a concise day by day abstract of the most recent information and analysts’ scores for Quest Diagnostics and similar firms with MarketBeat.com’s FREE day by day e mail e-newsletter.